首页> 外国专利> SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE AN S1P RECEIVER AGONIST AND A SUGAR SPIRIT.

SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE AN S1P RECEIVER AGONIST AND A SUGAR SPIRIT.

机译:包含S1P受体激动剂和糖精的固体药物成分。

摘要

A solid pharmaceutical composition suitable for oral administration, comprising: (a) an S1P receptor agonist; and (b) a sugar alcohol, wherein the S1P receptor agonist is selected from - a compound of the formula I ** see formula ** wherein R1 is a straight or branched (C12-22) carbon chain (C12 -22) - having in the chain a bond or a heteroatom selected from a double bond, a triple bond, O, S, NR6, wherein R 6 is H, alkyl, aralkyl, acyl or alkoxycarbonyl, and carbonyl, and / or - which may have as a substituent alkoxy, alkenyloxy, alkynyloxy, aralkyloxy, acyl, alkylamino, alkylthio, acylamino, alkoxycarbonyl, alkoxycarbonylamino acyloxy, alkylcarbamoyl, nitro, halogen, amino, hydroxyimino, hydroxy or carboxy; or R1 is - a phenylalkyl wherein alkyl is a straight or branched (C6-20) (C6-20) carbon chain; or - a phenylalkyl wherein alkyl is a straight or branched (C 1-30) (C 1-30) carbon chain wherein said phenylalkyl is substituted by - a straight or branched (C 6-20) carbon chain that is optionally substituted by halogen, - a straight or branched (C6-20) alkoxy chain that is optionally substituted by halogen, - a straight or branched (C6-20) alkenyloxy chain. - phenylalkoxy, halophenylalkoxy, phenylalkoxyalkyl, phenoxyalkoxy or phenoxyalkyl, - cycloalkylalkyl substituted by C6-20 alkyl, - heteroarylalkyl substituted by C 6-20 alkyl, - heterocyclic alkyl C6-20 or - heterocyclic alkyl substituted by C 2-20 alkyl, and in where the alkyl functional group may have - In the carbon chain, a bond or a heteroatom selected from a double bond, a triple bond, O, S, sulfinyl, sulfonyl, or NR6, wherein R6 is as defined above, and - as an alkoxy, alkenyloxy, alkynyloxy, aralkyloxy, acyl, alkylamino, alkylthio, acylamino, alkoxycarbonyl, alkoxycarbonylamino, acyloxy, alkylcarbamoyl, nitro, halogen, amino, hydroxy or carboxy substituent, and each of R2, R3, R4 and R5, independently , is H, C1-4 alkyl or acyl; and or its pharmacologically acceptable salt.
机译:一种适合口服的固体药物组合物,其包含:(a)S1P受体激动剂;和(b)糖醇,其中所述S1P受体激动剂选自:-式I **的化合物,参见式**,其中R1为直链或支链(C12-22)碳链(C12-22)-在链中的键或选自双键,三键,O,S,NR6的杂原子,其中R 6是H,烷基,芳烷基,酰基或烷氧羰基和羰基,和/或-取代基烷氧基,烯基氧基,炔基氧基,芳烷氧基,酰基,烷基氨基,烷硫基,酰基氨基,烷氧基羰基,烷氧基羰基氨基酰氧基,烷基氨基甲酰基,硝基,卤素,氨基,羟基亚氨基,羟基或羧基; R1是苯基烷基,其中烷基是直链或支链(C6-20)(C6-20)碳链;或或-苯基烷基,其中烷基为直链或支链(C 1-30)(C 1-30)碳链,其中所述苯基烷基被-直链或支链(C 6-20)碳链取代,其任选被卤素取代-直链或支链(C6-20)的烷氧基​​,其任选被卤素取代;-直链或支链(C6-20)的烯氧基。 -苯基烷氧基,卤代苯基烷氧基,苯基烷氧基烷基,苯氧基烷氧基或苯氧基烷基--被C6-20烷基取代的环烷基烷基--被C 6-20烷基取代的杂芳基烷基--杂环烷基C6-20或-被C 2-20烷基取代的杂环烷基其中烷基官能团可具有-在碳链中,选自双键,三键,O,S,亚磺酰基,磺酰基或NR6的键或杂原子,其中R6如上所定义,并且-烷氧基,烯基氧基,炔基氧基,芳烷氧基,酰基,烷基氨基,烷硫基,酰基氨基,烷氧基羰基,烷氧基羰基氨基,酰氧基,烷基氨基甲酰基,硝基,卤素,氨基,羟基或羧基取代基,且R 2,R 3,R 4和R 5各自独立地为H ,C 1-4烷基或酰基;和/或其药理学上可接受的盐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号